Hims & Hers Health reported fourth-quarter results on Monday that beat analysts’ expectations, but the stock sank in extended trading.
Related Posts
Hedge funds are buying more of these ‘rising star’ stocks, according to Goldman
A change in hedge fund popularity could signal where a stock is headed in the months to come, and there are some that may be […]
This under-the-radar oil producer is a buy and can rally more than 34%, TD Cowen says
Investors should take hold of SM Energy ahead of its earnings report, according to TD Cowen.
South Korea impeaches acting President Han Duck-soo, deepening political turmoil
Han’s predecessor, President Yoon Suk Yeol, was impeached a mere two weeks prior.